1-20 of 37
Djordje Atanackovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes of CD19 CAR-T-Cell Therapy with Axi-Cel in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) with and without Prior Autologous Stem Cell Transplant

David Tong Chen, Olga Goloubeva, Hanan Alkhaldi, Aaron P. Rapoport, Saurabh Dahiya, Nancy M. Hardy, Djordje Atanackovic, Mehmet Hakan Kocoglu, Forat Lutfi, Jean A. Yared
Journal: Blood
Blood (2022) 140 (Supplement 1): 9526–9527.
DOI: https://doi.org/10.1182/blood-2022-158281
Published: 2022
Journal Articles

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy

Clinical Trials & Observations
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M. Hardy, Xiaoxuan Fan, Stephanie V. Avila, Kapil K. Saharia, Jennifer S. Husson, Silke V. Niederhaus, Philip Margiotta, Seung T. Lee, Jennie Y. Law, Heather D. Mannuel, Erica Vander Mause, Sherri Bauman, Patricia Lesho, Kim Hankey, John Baddley, Mehmet Kocoglu, Jean A. Yared, Aaron P. Rapoport, Saurabh Dahiya
Journal: Blood
Blood (2022) 140 (2): 152–156.
DOI: https://doi.org/10.1182/blood.2022016175
Published: 2022
Includes: Supplemental data
Journal Articles

Imaging Biomarkers to Predict Outcomes in Patients with Large B-Cell Lymphoma with a Day 28 Partial Response By PET/CT Imaging Following CAR-T Therapy

Forat Lutfi, Olga Goloubeva, Dong Won Kim, Amer Kowatli, Anton Gryaznov, Philip Margiotta, Lisa R Matsumoto, David Gottlieb, Ali Bukhari, Caroline Dunne, Jennie Y. Law, Seung-Tae Lee, Kathleen Ruehle, Jean A. Yared, Mehmet Hakan Kocoglu, Djordje Atanackovic, Nancy M. Hardy, Wengen Chen, Aaron P. Rapoport, Saurabh Dahiya
Journal: Blood
Blood (2021) 138 (Supplement 1): 3876.
DOI: https://doi.org/10.1182/blood-2021-154225
Published: 2021
Journal Articles

Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy

Saurabh Dahiya, Tim Luetkens, Stephanie Avila, Saurabh Dahiya, Philip Margiotta, Kim Hankey, Patricia Lesho, Sherri Bauman, Nancy Smith, Kathleen Ruehle, Seung-Tae Lee, Jennie Y. Law, John Baddley, Mehmet Hakan Kocoglu, Jean A. Yared, Nancy M. Hardy, Aaron P. Rapoport, Djordje Atanackovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 1738.
DOI: https://doi.org/10.1182/blood-2021-153949
Published: 2021
Journal Articles

Eight-Day Point of Care CAR T-Cell Manufacturing on Clinimacs Prodigy from Healthy Donors As a Proof-of-Concept Study

Kim G. Hankey, Tim Luetkens, Stephanie Avila, John McLenithan, John Braxton, Karen Underwood, Clarissa Saba, Rena G. Lapidus, Forat Lufti, Philip Margiotta, Jean A. Yared, Nancy M. Hardy, Ulrike Abramowski-Mock, Joerg Mittelstaet, Ron Dudek, Xiaoxuan Fan, Djordje Atanackovic, Aaron P. Rapoport, Saurabh Dahiya
Journal: Blood
Blood (2021) 138 (Supplement 1): 2851.
DOI: https://doi.org/10.1182/blood-2021-154013
Published: 2021
Journal Articles

CD229 CAR T Cell Therapy for the Treatment of Relapsed B Cell Lymphoma

Michael Olson, Tim Luetkens, Fiorella Iglesias, Sabarinath Radhakrishnan, Jennie Y. Law, Stephanie Avila, Erica Vander Mause, Nicola J Camp, Erin Morales, Aaron P. Rapoport, Saurabh Dahiya, Joshua Brody, Alana Welm, Djordje Atanackovic
Journal: Blood
Blood (2021) 138 (Supplement 1): 2800.
DOI: https://doi.org/10.1182/blood-2021-154503
Published: 2021
Journal Articles

B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis

Nico Gagelmann, Francis Ayuketang Ayuk, MD, Djordje Atanackovic, MD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3113.
DOI: https://doi.org/10.1182/blood-2019-121967
Published: 2019
Journal Articles

"In Vivo Vaccination" Effect in Clinical Responders to Anti-Myeloma Monoclonal Antibody Isatuximab

Tim Luetkens, MD, Sara Yousef, PhD, Christa Shorter, BSc, Srinivas K. Tantravahi, MBBS, Mary Nicole Steinbach, NP, Janet Weidner, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1830.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1830.1830
Published: 2017
Journal Articles

Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma

Sabarinath Venniyil Radhakrishnan, MBBS, MD, Tim Luetkens, MD, Sara Yousef, PhD, Neelam Bhardwaj, PhD, Mary Nicole Steinbach, NP, Janet Weidner, Christa Shorter, BSc, Douglas W. Sborov, MD MSc, Djordje Atanackovic, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3142.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3142.3142
Published: 2017
Journal Articles

Exome Sequencing in Myeloma Pedigrees Implicates RAS1 and NOTCH Signaling Are Involved in Inherited Myeloma Risk

Rosalie G Waller, BS, Karen Curtin, PhD, Djordje Atanackovic, MD, Guido J Tricot, MD PhD, Steven M Lipkin, MD PhD, Nicola J Camp, PhD
Journal: Blood
Blood (2015) 126 (23): 2976.
DOI: https://doi.org/10.1182/blood.V126.23.2976.2976
Published: 2015
Journal Articles

A Genome-Wide Association Study of Myeloma Survival in Utah Uncovers Germline Variants That May Influence Survival of Multiple Myeloma Patients

Karen Curtin, PhD, Yi Zhao, MS, Donglei Hu, PhD, Guido J Tricot, MD PhD, Elad Ziv, MD, Djordje Atanackovic, MD, Nicola J Camp, PhD
Journal: Blood
Blood (2015) 126 (23): 2993.
DOI: https://doi.org/10.1182/blood.V126.23.2993.2993
Published: 2015
Journal Articles

Elevated Rates of Monoclonal Gammopathy in High-Risk Chronic Lymphocytic Leukemia Pedigrees

Nicola J Camp, PhD, Rosalie G Waller, BS, Cassandra Garner, BS, Guido J Tricot, MD PhD, Michael Tomasson, MD, Djordje Atanackovic, MD, Martha Glenn, MD
Journal: Blood
Blood (2015) 126 (23): 1449.
DOI: https://doi.org/10.1182/blood.V126.23.1449.1449
Published: 2015
Journal Articles

A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma

Thomas Martin, MD, Joshua Richter, MD, Ravi Vij, MD, Craig Cole, MD, Djordje Atanackovic, MD, Jeffrey Zonder, MD, Jonathan L. Kaufman, MD, William Bensinger, MD, Meletios A. Dimopoulos, Jesús San Miguel, MDPhD, Todd Zimmerman, MD, Nikoletta Lendvai, MDPhD, Parameswaran Hari, MD MRCP, MS, Enrique M. Ocio, MD PhD, Cristina Gasparetto, MD, Shaji Kumar, MD, Karl Hsu, MD, Eric Charpentier, MSc, Stephen A. Strickland, MD, Joseph Mikhael, MD
Journal: Blood
Blood (2015) 126 (23): 509.
DOI: https://doi.org/10.1182/blood.V126.23.509.509
Published: 2015
Journal Articles

Cytokine Interleukin-16 Supports Progression Of Multiple Myeloma Through Different Molecular Mechanisms

Julia Templin, Tim Luetkens, M.D., Djordje Atanackovic, M.D.
Journal: Blood
Blood (2013) 122 (21): 5367.
DOI: https://doi.org/10.1182/blood.V122.21.5367.5367
Published: 2013
Journal Articles

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Markus Ertmer, Djordje Atanackovic, Lucia Vankann, Stefan Wilop, MD, Eray Gökkurt, MD, Tim H Brümmendorf, Jens Panse, MD
Journal: Blood
Blood (2012) 120 (21): 4969.
DOI: https://doi.org/10.1182/blood.V120.21.4969.4969
Published: 2012
Journal Articles

Impact of the Expression of Genes Related to T Regulatory Cells on the Survival of Patients with Multiple Myeloma

Walter Moisés Tobias Braga, M.D., Bruna Raphaeli Silva, Adriana Bruscato Bortoluzo, Djordje Atanackovic, M.D., Gisele Wally Braga Colleoni, MD
Journal: Blood
Blood (2012) 120 (21): 4005.
DOI: https://doi.org/10.1182/blood.V120.21.4005.4005
Published: 2012
Journal Articles

Cancer-Testis Antigen MAGE-C2/CT10 Promotes Proliferation and Enhances Resistance to p53 Mediated Apoptosis in Multiple Myeloma

Nesrine Lajmi, Julia Templin, Sara Yousef, Tim Luetkens, Stefanie Spock, York Hildebrandt, Katrin Bartels, Yanran Cao, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic
Journal: Blood
Blood (2012) 120 (21): 1808.
DOI: https://doi.org/10.1182/blood.V120.21.1808.1808
Published: 2012
Journal Articles

Lenalidomide Maintenance Therapy After Toxicity-Reduced Myeloablative Allograft As Salvage Therapy for Efractory/Relapsed Myeloma Patients

Nicolaus Kröger, Evgeny Klyuchnikov, MD, Thomas Stübig, MD, Christine Wolschke, MD, Francis Ayuk, MD, Tatjana Zabelina, MD, York Hildebrandt, Ulrike Bacher, MD, Anita Badbaran, Georgia Schilling, MD, Orhan Sezer, MD, PhD, Djordje Atanackovic, M.D., Martin Kropff, MD, Axel R. Zander, MD
Journal: Blood
Blood (2011) 118 (21): 3024.
DOI: https://doi.org/10.1182/blood.V118.21.3024.3024
Published: 2011
Journal Articles

Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer Patients

Yanran Cao, M.D., Sacha Gnjatic, Ph.D., Vincent G. Brichard, M.D. Ph.D., Tim Luetkens, M.D., Sebastian Kobold, M.D., Katrin Bartels, Nasser Altorki, M.D., Friedrich Haag, M.D., Gerd Ritter, M.D., Carsten Bokemeyer, M.D., Lloyd J Old, M.D., Nicolaus Kroeger, M.D., Djordje Atanackovic, M.D.
Journal: Blood
Blood (2011) 118 (21): 5087.
DOI: https://doi.org/10.1182/blood.V118.21.5087.5087
Published: 2011
Journal Articles

Achievement of Sustained Molecular Remission Induces Long-Term Freedom From Disease After Autologous-Allogeneic Tandem Transplantation in Patients with Multiple Myeloma

Nicolaus Kröger, Tatjana Zabelina, MD, Francis Ayuk, MD, Christine Wolschke, MD, Haefaa Alchalby, Anita Badbaran, Djordje Atanackovic, M.D., Georgia Schilling, MD, Orhan Sezer, MD, PhD, Ulrike Bacher, MD, Thomas Stübig, MD, Boris Fehse, Ph.D., Axel R. Zander, MD
Journal: Blood
Blood (2011) 118 (21): 148.
DOI: https://doi.org/10.1182/blood.V118.21.148.148
Published: 2011